Поиск | SocioMint

Akash Motar добавлена новая статья Другое
2026-09-07 16:58:45 -

Alzheimer’s Disease Market Forecast : Size, Share, Trends, and Competitive Analysis
" According to the latest report published by Data Bridge Market Research, the Alzheimer’s Disease Market Data Bridge Market Research analyzes that the Alzheimer’s disease market which was USD 5.10 billion in 2022, is likely to reach USD 9.73 billion by 2030, and is expected to undergo a CAGR of 8.40% during the forecast period. Global Alzheimer’s Disease...

0 Комментарии 0 Поделились 65 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Rohit Sharma добавлена новая статья Другое
2026-07-14 09:03:01 -

Alzheimer's Therapeutics Market: Where Biopharma Leaders Are Investing for the Next Decade
Alzheimer's Therapeutics Market According to the latest report published by Data Bridge Market Research, the Alzheimer's Therapeutics Market Alzheimer’s therapeutics market was valued at USD 5.99 billion in 2024 and is expected to reach USD 11.39 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of...

0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Workin Kshdbmr добавлена новая статья Networking
2026-09-04 10:59:32 -

What Are the Most Promising Advances in Alzheimer’s Disease Treatment?
According to the latest report published by Data Bridge Market Research, the Alzheimer’s Disease Treatment Market CAGR Value The global Alzheimer’s Disease Treatment market size was valued at USD 5.50 billion in 2025 and is expected to reach USD 10.79 billion by 2033, at a CAGR of 8.79% during the forecast period An influential Alzheimer’s Disease Treatment...

0 Комментарии 0 Поделились 104 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Kushalmarket Researchfuture добавлена новая статья Другое
2026-08-03 11:21:17 -

Investigating Neurological Research and the Expanding Global Rolipram Market Scope
The human brain remains one of the most complex and heavily studied frontiers in modern medicine. Neurological diseases, cognitive decline, and chronic central nervous system (CNS) disorders present immense challenges to the global healthcare system. In the relentless pursuit of effective treatments, pharmacologists and neuroscientists are intensely focused on cellular signaling pathways and...

0 Комментарии 0 Поделились 993 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!